is compounded semaglutide being taken off the market FDA crackdown on off-brand Ozempic products set to take effect, threatening supply and access for many Pharma's mess of its own

High Cost and Barriers to Access Costs can limit access to GLP-1 drugs for weight loss

References 1.The Lancet Psychiatry Global Burden of Disease 2021: Mental health messages

These results are promising, but it is important to understand that individual outcomes vary based on starting weight, diet, activity level, and adherence to treatment protocols

Poor sleep patterns due to pain or discomfort worsen the mental clarity needed for daily tasks

Treatment Medication Costs The total drug acquisition costs for each intervention over the 72 weeks were calculated based on the dosing schedules from the SURMOUNT-5 trial